Ciprofloxacin
Ciprofloxacin is a fluoroquinolone antibiotic used as tablets and IV injection for infections such as urinary tract, respiratory, skin, bone and abdominal infections, and as eye and ear drops or eye ointment for eye and ear infections.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 152 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
Ciprofloxacin is a familiar fluoroquinolone antibiotic, on the market since about 1987 and available as a generic, that kills bacteria by blocking two enzymes they need to copy and repair DNA; it treats urinary, respiratory, skin, bone and abdominal infections (and eye and ear infections as drops), though it is now held back for when a safer option will not work. Most people manage a course with little more than nausea or diarrhea. Watch for its boxed-warning effects (tendon pain, burning or tingling in the hands or feet, mood or thinking changes), which can be permanent, and stop it and call your prescriber right away if any appear.
Clinical pearls
- Take it at least 2 hours before or 6 hours after antacids, multivitamins, calcium, iron, zinc or dairy, which block absorption.
- Tizanidine must never be taken with ciprofloxacin, and theophylline should be avoided because the combination can be fatal.
- On warfarin or a sulfonylurea for diabetes, expect closer INR or blood sugar checks, since ciprofloxacin can push both too far.
- Tendon rupture risk is higher if you are over 60, take a corticosteroid like prednisone, or have had a kidney, heart or lung transplant.
⚠️ FDA Boxed Warning — the FDA’s strongest safety alert ▾
Fluoroquinolones like ciprofloxacin can cause disabling and possibly permanent side effects, often more than one at once. These include tendon inflammation or rupture, nerve damage (pain, burning, tingling, numbness, weakness), and effects on the brain and mood.
Stop ciprofloxacin and call your doctor immediately if you notice any of these. It can also make muscle weakness worse in people with myasthenia gravis, who should avoid it. Because of these risks, it should be saved for acute exacerbation of chronic bronchitis, acute uncomplicated cystitis (bladder infection) and acute sinusitis only when no other treatment options exist.
Patient information guide A plain-language walkthrough of Ciprofloxacin, written from its FDA label.
What Ciprofloxacin is used for
▾
Ciprofloxacin is used for infections caused by susceptible bacteria, and the approved uses depend on the product.
- Tablets and IV injection: skin and skin structure infections, bone and joint infections, complicated intra-abdominal infections, chronic bacterial prostatitis, lower respiratory tract infections (including acute exacerbation of chronic bronchitis), urinary tract infections and acute sinusitis.
- Tablets only: infectious diarrhea, typhoid fever, uncomplicated cervical and urethral gonorrhea, and acute uncomplicated cystitis.
- IV injection only: nosocomial pneumonia and empirical therapy for febrile neutropenic patients.
- Tablets and IV injection: inhalational anthrax post-exposure and plague, including in children.
- Eye drops: corneal ulcers and bacterial conjunctivitis.
- Ciloxan eye ointment: bacterial conjunctivitis.
- Ear drops (Cetraxal and Ciprofloxacin Otic): acute otitis externa.
How Ciprofloxacin works
▾
Ciprofloxacin is a fluoroquinolone antibiotic that kills bacteria. It blocks two bacterial enzymes, DNA gyrase and topoisomerase IV. Bacteria need them to copy, read and repair their DNA, so blocking them stops the bacteria from surviving.
Ciprofloxacin dosage
▾
Tablets are swallowed, usually every 12 hours, with treatment lasting from a single dose to several weeks depending on the infection. Food delays absorption slightly but does not stop it from working.
- IV injection is given in a vein by a healthcare team.
- Eye and ear products are used only on the affected eye or ear, with schedules that differ by product.
- Take ciprofloxacin 2 hours before or 6 hours after antacids, multivitamins, and calcium, iron, zinc or dairy products.
Follow your prescriber’s directions and the label.
Dosing details from the FDA-approved label
From the Ciprofloxacin prescribing information (“Dosage and Administration”). Doses are set by your prescriber for your product, condition, kidney function and age — never change a dose on your own.
- Skin and Skin Structure
- 500 mg to 750 mg every 12 hours for 7 to 14 days
- Bone and Joint
- 500 mg to 750 mg every 12 hours for 4 to 8 weeks
- Complicated Intra-Abdominal
- 500 mg every 12 hours for 7 to 14 days
- Used in conjunction with metronidazole
- Infectious Diarrhea
- 500 mg every 12 hours for 5 to 7 days
- Typhoid Fever
- 500 mg every 12 hours for 10 days
- Uncomplicated Gonorrhea (Uncomplicated Urethral and Cervical Gonococcal Infections)
- 250 mg single dose
- Inhalational anthrax (post-exposure)
- 500 mg every 12 hours for 60 days
- Begin drug administration as soon as possible after suspected or confirmed exposure
- Plague
- 500 mg to 750 mg every 12 hours for 14 days
- Urinary Tract Infections
- 250 mg to 500 mg every 12 hours for 7 to 14 days
- Adults with creatinine clearance 30 to 50 mL/min: 250 to 500 mg every 12 hours; 5 to 29 mL/min: 250 to 500 mg every 18 hours
- Pediatric Complicated Urinary Tract Infection or Pyelonephritis (1 to 17 years of age)
- 10 mg/kg to 20 mg/kg every 12 hours for 10 to 21 days
- Maximum: 750 mg per dose; not to be exceeded even in patients weighing more than 51 kg
Read the label’s full dosing text
2 DOSAGE AND ADMINISTRATION CIPRO Tablets and Oral Suspension should be administered orally as described in the appropriate Dosage Guidelines tables. Adult Dosage Guidelines Infection Dose Frequency Duration Skin and Skin Structure 500 -750 mg every 12 hours 7 to 14 days Bone and Joint 500-750 mg every 12 hours 4 to 8 weeks Complicated Intra-Abdominal 500 mg every 12 hours 7 to 14 days Infectious Diarrhea 500 mg every 12 hours 5 to 7 days Typhoid Fever 500 mg every 12 hours 10 days Uncomplicated Gonorrhea 250 mg single dose single dose Inhalational anthrax (post-exposure) 500 mg every 12 hours 60 days Plague 500–750 mg every 12 hours 14 days Chronic Bacterial Prostatitis 500 mg every 12 hours 28 days Lower Respiratory Tract 500 -750 mg every 12 hours 7 to 14 days Urinary Tract 250-500 mg every 12 hours 7 to 14 days Acute Uncomplicated Cystitis 250 mg every 12 hours 3 days Acute Sinusitis 500 mg every 12 hours 10 days • Adults with creatinine clearance 30–50 mL/min 250–500 mg q 12 h (2.3 ) • Adults with creatinine clearance 5–29 mL/min 250–500 mg q 18 h ( 2.3 ) • Patients on hemodialysis or peritoneal dialysis 250–500 mg q 24 h (after dialysis) ( 2.3 ) Pediatric Oral Dosage Guidelines Infection Dose Frequency Duration Complicated UTI and Pyelonephritis (1 to 17 years of age) 10–20 mg/kg (maximum 750 mg per dose) Every 12 hours 10–21 days Inhalational Anthrax (Post-Exposure) 15 mg/kg (maximum 500 mg per dose) Every 12 hours 60 days Plague 15 mg/kg (maximum 500 mg per dose) Every 8 to 12 hours 14 days 2.1 Dosage in Adults The determination of dosage and duration for any particular patient must take into consideration the severity and nature of the infection, the susceptibility of the causative microorganism, the integrity of the patient’s host-defense mechanisms, and the status of renal and hepatic function. CIPRO Tablets or CIPRO for Oral Suspension may be administered to adult patients when clinically indicated at the discretion of the physician. Administer CIPRO for Oral Suspension using the co-packaged graduated spoon [see Dosage and Administration ( 2.7 )]. Table 1: Adult Dosage Guidelines Infection Dose Frequency Usual Durations Generally ciprofloxacin should be continued for at least 2 days after the signs and symptoms of infection have disappeared, except for inhalational anthrax (post-exposure).
Excerpted — the section continues on the label. Read the full Dosage and Administration section on DailyMed →
Ciprofloxacin side effects
▾
The most common side effects reported in clinical trials were:
Common side effects
- Nausea
- Diarrhea
- Abnormal liver function tests
- Vomiting
- Rash
When to get medical help
- Stop the medicine and call your doctor right away if you have tendon pain, swelling or inflammation, or a tendon rupture.
- Call your doctor right away for pain, burning, tingling, numbness or weakness in your arms or legs.
- Get help for hallucinations, severe anxiety, depression, thoughts of suicide, confusion, severe headaches or seizures.
- Seek emergency help for signs of a serious allergic reaction, such as rash, swelling of the face or throat, or trouble breathing.
- Call your doctor for yellow skin or eyes, dark urine, loss of appetite or belly tenderness, which can signal liver problems.
- Call your doctor if you have severe or lasting diarrhea, which may be C. difficile colitis, even weeks after treatment.
- Report a fast, pounding or irregular heartbeat or fainting.
- Report worsening muscle weakness if you have myasthenia gravis.
Tendon pain, nerve symptoms, mood changes, seizures, severe allergic reactions and liver problems need urgent medical attention.
Ciprofloxacin warnings and precautions
▾
- Disabling and possibly permanent effects: tendon rupture, nerve damage, and effects on the brain and mood can occur together.
- Myasthenia gravis can get worse, sometimes severely.
- Serious allergic reactions can happen after the first dose.
- Liver injury, including liver failure, has been reported.
- Heart rhythm changes (QT prolongation) and aortic aneurysm or dissection are risks.
- C. difficile diarrhea can appear even weeks after treatment.
- Sun sensitivity can cause exaggerated sunburn.
Ciprofloxacin interactions
▾
Ciprofloxacin interacts with many medicines.
- Tizanidine: contraindicated because of dangerous low blood pressure and sedation.
- Theophylline: can cause serious reactions, so avoid.
- QT-prolonging drugs: heart rhythm risk.
- Duloxetine and zolpidem: levels rise, so avoid.
- Antacids, multivitamins, and calcium, iron, zinc or dairy products: reduce absorption, so separate doses.
- Diabetes medicines: can cause severe low blood sugar.
- Warfarin: stronger blood-thinning effect.
- Phenytoin, cyclosporine, methotrexate, clozapine, ropinirole, sildenafil, caffeine, NSAIDs and probenecid: use with caution and monitoring.
Interactions listed in the FDA-approved label
From the Ciprofloxacin prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
- Tizanidine: Potentiation of hypotensive and sedative effects of tizanidine. Contraindicated
- Theophylline: May result in increased risk of central nervous system (CNS) or other adverse reactions; serious and fatal reactions. Avoid use; if concomitant use cannot be avoided, monitor serum levels of theophylline and adjust dosage as appropriate
- Drugs known to prolong QT interval: Ciprofloxacin may further prolong the QT interval. Avoid use
- Oral antidiabetic drugs: Glucose-lowering effect potentiated; severe hypoglycemia and fatalities have been reported, mainly with sulfonylureas. Use with caution; monitor blood glucose
- Phenytoin: Altered serum levels of phenytoin (increased and decreased). Use with caution; monitor phenytoin therapy, including serum concentration, during and shortly after coadministration
- Cyclosporine: Transient elevations in serum creatinine. Use with caution; monitor renal function, in particular serum creatinine
- Anti-coagulant drugs (e.g., warfarin): Increase in anticoagulant effect. Use with caution; monitor prothrombin time and INR frequently during and shortly after coadministration
- Methotrexate: Inhibition of methotrexate renal tubular transport, potentially increasing methotrexate plasma levels and risk of toxic reactions. Use with caution; carefully monitor patients
- Duloxetine: Five-fold increase in duloxetine exposure. Avoid use; if unavoidable, monitor for duloxetine toxicity
- Antacids, sucralfate, multivitamins and other products containing multivalent cations (including dairy products): Decrease ciprofloxacin absorption, resulting in lower serum and urine levels. Take ciprofloxacin at least two hours before or six hours after these products
Read the label’s full interactions text
7 DRUG INTERACTIONS Ciprofloxacin is an inhibitor of human cytochrome P450 1A2 (CYP1A2) mediated metabolism. Coadministration of ciprofloxacin with other drugs primarily metabolized by CYP1A2 results in increased plasma concentrations of these drugs and could lead to clinically significant adverse events of the coadministered drug. Table 11: Drugs That are Affected by and Affecting Ciprofloxacin Drugs That are Affected by Ciprofloxacin Drug(s) Recommendation Comments Tizanidine Contraindicated Concomitant administration of tizanidine and ciprofloxacin is contraindicated due to the potentiation of hypotensive and sedative effects of tizanidine [ see Contraindications (4.2) ] . Theophylline Avoid Use (Plasma Exposure Likely to be Increased and Prolonged) Concurrent administration of ciprofloxacin with theophylline may result in increased risk of a patient developing central nervous system (CNS) or other adverse reactions. If concomitant use cannot be avoided, monitor serum levels of theophylline and adjust dosage as appropriate [ s ee Warnings and Precautions ( 5.10 )] . Drugs Known to Prolong QT Interval Avoid Use Ciprofloxacin may further prolong the QT interval in patients receiving drugs known to prolong the QT interval (for example, class IA or III antiarrhythmics, tricyclic antidepressants, macrolides, antipsychotics) [see Warnings and Precautions (5.12) and Use in Specific Populations (8.5) ]. Oral antidiabetic drugs Use with caution Glucose-lowering effect potentiated Hypoglycemia sometimes severe has been reported when ciprofloxacin and oral antidiabetic agents, mainly sulfonylureas (for example, glyburide, glimepiride), were coadministered, presumably by intensifying the action of the oral antidiabetic agent. Fatalities have been reported . Monitor blood glucose when ciprofloxacin is coadministered with oral antidiabetic drugs [ s ee Adverse Reactions (6.1) ] .
Excerpted — the section continues on the label. Read the full Drug Interactions section on DailyMed →
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before taking Ciprofloxacin
▾
- Do not use if you are allergic to ciprofloxacin or other quinolones, or if you take tizanidine.
- Tell your doctor about myasthenia gravis, past tendon or nerve problems, seizures, heart rhythm problems, or aortic aneurysm.
- Adults over 60, people on corticosteroids, and transplant recipients have a higher tendon risk.
- Children: used only for certain infections because of higher joint-related side effects.
- Pregnancy: tell your doctor; available human data have not shown a clear risk of birth defects.
- Breastfeeding is not recommended during treatment and for 2 days after, though you may pump and discard milk.
Ciprofloxacin overdose
▾
In overdose, reversible kidney toxicity has been reported. Treatment includes emptying the stomach, supportive care, monitoring kidney function and staying well hydrated. Antacids containing magnesium, aluminum or calcium can reduce absorption. Dialysis removes very little of the drug.
What Ciprofloxacin does in the body
▾
Ciprofloxacin has a bactericidal effect, meaning it kills bacteria. It does this by inhibiting enzymes that bacteria need to replicate and repair their DNA. It also inhibits the human liver enzyme CYP1A2, which is why it can raise levels of other drugs.
How your body processes Ciprofloxacin
▾
About 70% of an oral tablet dose is absorbed, with peak blood levels 1 to 2 hours after dosing. Food delays absorption slightly. The drug spreads widely into tissues, including the prostate, lungs, skin, bone and sinuses. About 40 to 50% of an oral dose leaves in urine unchanged, and the half-life is about 4 hours with normal kidney function.
How to store Ciprofloxacin
▾
Store at 20°C to 25°C (68° to 77°F) .
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
Supplements & herbs that interact with Ciprofloxacin
163 supplements and herbal products have documented interactions with Ciprofloxacin in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 8
- Moderate · 133
- Minor · 22
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Nutrient depletion considerations
Ciprofloxacin has been associated with lower levels of 11 nutrients in the clinical literature. This does not mean a deficiency will occur — it means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.
- Higher significance · 10
- Moderate · 1
Educational information from a licensed clinical database (Natural Medicines) — not medical advice. Do not start or stop medications or supplements without professional guidance.
Ciprofloxacin: pharmacist answers to common questions
Quick, plain-English answers to the questions patients ask most about Ciprofloxacin — the kind of thing our pharmacy team would talk through with you at the counter.
What is ciprofloxacin used for?
▾
How should I take my ciprofloxacin tablets?
▾
What side effects should I expect?
▾
When should I stop it and call my doctor?
▾
Are there medicines I should avoid with it?
▾
Is it safe in pregnancy or while breastfeeding?
▾
Is Ciprofloxacin available over the counter?
▾
When was Ciprofloxacin first available?
▾
Who makes Ciprofloxacin?
▾
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
More about Ciprofloxacin on HelloPharmacist
Ciprofloxacin forms and strengths (how it comes)
Ciprofloxacin is available in 5 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Tablet
How this form is used
- Ciprofloxacin tablets are used for skin, bone and joint, intra-abdominal, respiratory and urinary tract infections, infectious diarrhea and typhoid fever.
- Ciprofloxacin tablets are also used for uncomplicated gonorrhea, anthrax post-exposure, plague, chronic bacterial prostatitis and acute sinusitis.
- Cipro tablets are taken by mouth, usually every 12 hours; length of treatment ranges from a single dose to 60 days depending on the infection.
- Separate ciprofloxacin tablets from antacids, multivitamins, and calcium, iron, zinc or dairy products: take ciprofloxacin 2 hours before or 6 hours after them.
Eye drops
How this form is used
- Ciprofloxacin ophthalmic solution is used for corneal ulcers caused by susceptible bacteria.
- Ciprofloxacin ophthalmic solution is used for bacterial conjunctivitis.
- Ciprofloxacin ophthalmic solution for corneal ulcers is dosed very frequently at first, then less often over 14 days or more.
- Ciprofloxacin ophthalmic solution for bacterial conjunctivitis is used every two hours while awake for two days, then every four hours while awake for five days.
Injection
How this form is used
- Ciprofloxacin injection is used for skin, bone and joint, complicated intra-abdominal and lower respiratory tract infections.
- Ciprofloxacin injection is also used for nosocomial pneumonia, febrile neutropenia (with piperacillin), anthrax post-exposure, plague, chronic bacterial prostatitis, urinary tract infections and acute sinusitis.
- Ciprofloxacin injection is given intravenously, every 8 to 12 hours depending on the infection, as directed by the prescriber.
Ear drops
How this form is used
- Cetraxal is used for acute otitis externa caused by susceptible Pseudomonas aeruginosa or Staphylococcus aureus.
- Ciprofloxacin Otic is used for acute otitis externa caused by susceptible Pseudomonas aeruginosa or Staphylococcus aureus.
- Cetraxal: one single-use container goes into the affected ear twice daily, about 12 hours apart, for 7 days.
- Cetraxal: warm the container in your hands for at least 1 minute, then lie with the affected ear up for at least 1 minute after the drops.
- Ciprofloxacin Otic: one single-dose container goes into the affected ear twice daily for 7 days; discard any unused portion.
Eye ointment
How this form is used
- Ciloxan ointment is used for bacterial conjunctivitis caused by susceptible bacteria.
- Ciloxan ointment: a ½ inch ribbon is applied into the conjunctival sac three times a day for two days, then twice a day for five days.
Ciprofloxacin on the U.S. market: products, makers and brands
How Ciprofloxacin appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
49 companies list 185 Ciprofloxacin product records with the FDA, mostly as tablet, eye drops, injection; the earliest marketing or approval year on record is 1987. Brand names on the directory include Cipro Oral Suspension, Cipro Tablets, Cipro XR Extended-release Tablets and 7 more; the rest are generics.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (18) · Kit (10) · Crystal (1) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How widely Ciprofloxacin is used (Medicaid data)
A general measure of how commonly Ciprofloxacin is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Ciprofloxacin is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Ciprofloxacin prescribed? Of the 1,601 medications we measure, Ciprofloxacin ranks #183 by Medicaid prescriptions — more than 89% of them.
Utilization by Ciprofloxacin product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
ciprofloxacin 500 MG Oral Tablet Most dispensed
Summed across the 23 of 758 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 309309
ciprofloxacin 3 MG/ML Ophthalmic Solution
Summed across the 6 of 79 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 309307
ciprofloxacin 250 MG Oral Tablet
Summed across the 8 of 397 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197511
ciprofloxacin 750 MG Oral Tablet
Summed across the 8 of 100 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197512
200 ML ciprofloxacin 2 MG/ML Injection
Summed across the 3 of 12 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1665212
ciprofloxacin 50 MG/ML Oral Suspension
Summed across the 1 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 309308
ciprofloxacin 100 MG/ML Oral Suspension
Summed across the 1 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 309310
ciprofloxacin 0.003 MG/MG Ophthalmic Ointment
Summed across the 1 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 309306
ciprofloxacin 2 MG/ML Otic Solution
Summed across the 1 of 4 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 848956
100 ML ciprofloxacin 2 MG/ML Injection
Summed across the 3 of 10 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1665210
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Ciprofloxacin, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 55 of 1,366 listed Ciprofloxacin NDCs with Medicaid activity.
Compare Ciprofloxacin products
A representative set of FDA-listed product records for Ciprofloxacin — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Ear drops | ||||
| 0.5 mg/0.25 mL | Auricular (otic) | Genus Lifesciences | ANDA | View NDC → |
| 💊Eye drops | ||||
| 3 mg/mL | Ophthalmic | A-S Medication Solutions | ANDA | View NDC → |
| 3 mg/mL | Ophthalmic | A-S Medication Solutions × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 3 mg/mL | Ophthalmic | Advagen Pharma Limited | ANDA | View NDC → |
| 3 mg/mL | Ophthalmic | Advanced Rx of Tennessee, LLC | ANDA | View NDC → |
| 3 mg/mL | Ophthalmic | Altaire Pharmaceuticals Inc. | ANDA | View NDC → |
| 3 mg/mL | Ophthalmic | Asclemed USA, Inc. | ANDA | View NDC → |
| 3 mg/mL | Ophthalmic | Asclemed USA, Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| 3 mg/mL | Ophthalmic | Hawaii Repack, Inc | ANDA | View NDC → |
| 3 mg/mL | Ophthalmic | Leading Pharma, LLC | ANDA | View NDC → |
| 3 mg/mL | Ophthalmic | NuCare Pharmaceuticals,Inc. × 2 listings | ANDA | View NDC → |
| 3 mg/mL | Ophthalmic | NuCare Pharmaceuticals,Inc. × 3 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 3 mg/mL | Ophthalmic | Preferred Pharmaceuticals, Inc. | ANDA | View NDC → |
| 3 mg/mL | Ophthalmic | Preferred Pharmaceuticals Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| 3 mg/mL | Ophthalmic | Proficient Rx LP | ANDA | View NDC → |
| 3 mg/mL | Ophthalmic | Proficient Rx LP | NDA AUTHORIZED GENERIC | View NDC → |
| 3 mg/mL | Ophthalmic | Redpharm Drug | ANDA | View NDC → |
| 3 mg/mL | Ophthalmic | Redpharm Drug | NDA AUTHORIZED GENERIC | View NDC → |
| 3 mg/mL | Ophthalmic | Remedyrepack Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| 3 mg/mL | Ophthalmic | Sandoz Inc | NDA AUTHORIZED GENERIC | View NDC → |
| 3 mg/mL | Ophthalmic | Sportpharm LLC | ANDA | View NDC → |
| 💊Eye ointment | ||||
| 3 mg/g | Ophthalmic | Sandoz Inc | NDA | View NDC → |
| 💊Injection | ||||
| 200 mg/100 mL | Intravenous | Hospira, Inc. | ANDA | View NDC → |
| 400 mg/200 mL | Intravenous | Hospira, Inc. | ANDA | View NDC → |
| 400 mg/200 mL | Intravenous | ProPharma Distribution | ANDA | View NDC → |
| 2 mg/mL | Intravenous | Sagent Pharmaceuticals × 2 listings | ANDA | View NDC → |
| 💊Tablet | ||||
| 250 mg | Oral | A-S Medication Solutions × 3 listings | ANDA | View NDC → |
| 500 mg | Oral | A-S Medication Solutions × 7 listings | ANDA | View NDC → |
| 250 mg | Oral | Actavis Pharma, Inc. | ANDA | View NDC → |
| 500 mg | Oral | Actavis Pharma, Inc. | ANDA | View NDC → |
| 500 mg | Oral | Advanced Rx of Tennessee, LLC | ANDA | View NDC → |
| 500 mg | Oral | Advanced Rx Pharmacy of Tennessee, LLC | ANDA | View NDC → |
| 500 mg | Oral | American Health Packaging × 2 listings | ANDA | View NDC → |
| 250 mg | Oral | Amneal Pharmaceuticals NY LLC | ANDA | View NDC → |
| 500 mg | Oral | Amneal Pharmaceuticals NY LLC | ANDA | View NDC → |
| 750 mg | Oral | Amneal Pharmaceuticals NY LLC | ANDA | View NDC → |
| 500 mg | Oral | Aphena Pharma Solutions - Tennessee, LLC × 3 listings | ANDA | View NDC → |
| 250 mg | Oral | Asclemed USA, Inc. × 2 listings | ANDA | View NDC → |
| 500 mg | Oral | Asclemed USA, Inc. × 2 listings | ANDA | View NDC → |
| 250 mg | Oral | Aurobindo Pharma Limited × 3 listings | ANDA | View NDC → |
| 500 mg | Oral | Aurobindo Pharma Limited × 3 listings | ANDA | View NDC → |
| 750 mg | Oral | Aurobindo Pharma Limited × 3 listings | ANDA | View NDC → |
| 250 mg | Oral | Bryant Ranch Prepack × 3 listings | ANDA | View NDC → |
| 500 mg | Oral | Bryant Ranch Prepack × 3 listings | ANDA | View NDC → |
| 750 mg | Oral | Coupler LLC | ANDA | View NDC → |
| 250 mg | Oral | Direct Rx | ANDA | View NDC → |
| 250 mg | Oral | Direct_Rx | ANDA | View NDC → |
| 500 mg | Oral | Direct_Rx | ANDA | View NDC → |
| 500 mg | Oral | Major Pharmaceuticals | ANDA | View NDC → |
| 250 mg | Oral | Method Pharmaceuticals, LLC | ANDA | View NDC → |
| 500 mg | Oral | Method Pharmaceuticals, LLC | ANDA | View NDC → |
| 500 mg | Oral | Northwind Health Company, LLC | ANDA | View NDC → |
| 500 mg | Oral | NuCare Pharmaceutical, Inc. | ANDA | View NDC → |
| 250 mg | Oral | NuCare Pharmaceuticals,Inc. × 2 listings | ANDA | View NDC → |
| 500 mg | Oral | NuCare Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 500 mg | Oral | NuCare Pharmaceuticals,Inc. × 3 listings | ANDA | View NDC → |
| 250 mg | Oral | PD-Rx Pharmaceuticals, Inc. | ANDA | View NDC → |
| 500 mg | Oral | PD-Rx Pharmaceuticals, Inc. | ANDA | View NDC → |
| 750 mg | Oral | PD-Rx Pharmaceuticals, Inc. | ANDA | View NDC → |
| 250 mg | Oral | PharmPak, Inc. | ANDA | View NDC → |
| 500 mg | Oral | PharmPak, Inc. | ANDA | View NDC → |
| 250 mg | Oral | Preferred Pharmaceuticals Inc. | ANDA | View NDC → |
| 250 mg | Oral | Proficient Rx LP × 2 listings | ANDA | View NDC → |
| 500 mg | Oral | Proficient Rx LP | ANDA | View NDC → |
| 750 mg | Oral | Proficient Rx LP | ANDA | View NDC → |
| 500 mg | Oral | Redpharm Drug | ANDA | View NDC → |
| 500 mg | Oral | Remedyrepack Inc. | ANDA | View NDC → |
| 250 mg | Oral | Rising Pharmaceuticals, Inc. | ANDA | View NDC → |
| 500 mg | Oral | Rising Pharmaceuticals, Inc. | ANDA | View NDC → |
| 750 mg | Oral | Rising Pharmaceuticals, Inc. | ANDA | View NDC → |
| 250 mg | Oral | Solco Healthcare US, LLC | ANDA | View NDC → |
| 500 mg | Oral | Solco Healthcare US, LLC | ANDA | View NDC → |
| 250 mg | Oral | St. Mary's Medical Park Pharmacy | ANDA | View NDC → |
| 500 mg | Oral | St. Mary's Medical Park Pharmacy | ANDA | View NDC → |
| 250 mg | Oral | Umasuto, LLC | ANDA | View NDC → |
| 500 mg | Oral | Umasuto, LLC | ANDA | View NDC → |
| 750 mg | Oral | Umasuto, LLC | ANDA | View NDC → |
| 250 mg | Oral | Yiling Pharmaceutical, Inc. | ANDA | View NDC → |
| 500 mg | Oral | Yiling Pharmaceutical, Inc. | ANDA | View NDC → |
| 💊Kits | ||||
| — | — | Bayer HealthCare Pharmaceuticals Inc. × 2 listings | NDA | View NDC → |
| — | — | Chartwell RX, LLC × 2 listings | ANDA | View NDC → |
Showing 116 of 185 products — FDA National Drug Code Directory. See every product, package size and price: browse all 185 Ciprofloxacin NDCs →
Ciprofloxacin side effects reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Ciprofloxacin — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Ciprofloxacin in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Ciprofloxacin FDA approval history
How Ciprofloxacin went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Ciprofloxacin recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list 4 Ciprofloxacin recalls since July 2021. Three of them are still ongoing or began in the last six months and are listed first. A recall names specific lots from one company, so check the lot number on your own bottle rather than assuming every product is affected; your pharmacist can check whether your supply came from an affected lot.
- Ciprofloxacin Ophthalmic Solution USP, 0.3% as base, package in 5 mL bottles, Rx Only, Distributed by: Leading Pharma LLC, Fairfield, NJ. Manufactured by: FDC Limited, Maharashtra, India, NDC 69315-3… Lots: Lot: 084A067, Exp 12/31/2025 FDA record D-0282-2025 →
- Ciprofloxacin Ophthalmic Solution USP, 0.3% as base, Sterile, package in 5 mL bottles, Rx Only, Distributed by: Leading Pharma LLC, Fairfield, NJ. Manufactured by: FDC Limited, Maharashtra, India, ND… Lots: Lot: 083L111, Exp. 11/30/2025; 084A032, Exp. 12/31/2025 FDA record D-0182-2025 →
- Ciprofloxacin ophthalmic solution USP, 0.3% as base, package in bottles: a) 10 mL (NDC 69315-308-10), b) 2.5 mL (NDC 69315-308-02), Rx Only, Distributed by: Leading Pharma LLC, Fairfield, NJ. Manufac… Lots: Lot#: a) 084C040, Exp 02/28/2026; b) 084A024, Exp12/31/2025. FDA record D-0623-2024 →
- Ciprofloxacin Ophthalmic Solution 0.3%, 5 mL bottle, Rx only, MFG: Sandoz Pharma, NDC 61314-656-05 Lots: McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that i… FDA record D-1044-2022 →
Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Sep 24, 2026.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 2551 7 dose forms · 14 strengths
-
Dose form (SCDF) Extended Release Oral Tablet RxCUI 597445No current FDA listingClinical drug / strength (SCD) 24 HR ciprofloxacin 1000 MGRxCUI 40392124 HR ciprofloxacin 500 MGRxCUI 359383 -
Dose form (SCDF) Injection RxCUI 1665209In current FDA listingsClinical drug / strength (SCD) 40 ML ciprofloxacin 10 MG/MLRxCUI 1665229100 ML ciprofloxacin 2 MG/MLRxCUI 1665210200 ML ciprofloxacin 2 MG/MLRxCUI 1665212 -
Dose form (SCDF) Ophthalmic Ointment RxCUI 376483In current FDA listingsClinical drug / strength (SCD) 0.003 MG/MGRxCUI 309306 -
Dose form (SCDF) Ophthalmic Solution RxCUI 376202In current FDA listingsClinical drug / strength (SCD) 3 MG/MLRxCUI 309307 -
Dose form (SCDF) Oral Suspension RxCUI 371524No current FDA listing -
Dose form (SCDF) Oral Tablet RxCUI 371525In current FDA listings -
Dose form (SCDF) Otic Solution RxCUI 848955In current FDA listingsClinical drug / strength (SCD) 2 MG/MLRxCUI 848956
Look up RxCUI 2551 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Ciprofloxacin supply and shortage status
Whether Ciprofloxacin is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
💵 What Ciprofloxacin costs pharmacies (NADAC benchmark)
The national average invoice price pharmacies pay for the drug itself, from CMS's NADAC survey (data as of Sep 30, 2026). This is a supply-cost benchmark — not a retail price and not what you'd pay at the counter.
| Form | Strength | Pharmacy acquisition benchmark | |
|---|---|---|---|
| Tablet, Film Coated · Oral | 500 mg | $0.123 per tablet | NDC details & price history |
| Tablet, Film Coated · Oral | 250 mg | $0.088 per tablet | NDC details & price history |
| Tablet, Film Coated · Oral | 750 mg | $0.250 per tablet | NDC details & price history |
| Tablet, Coated · Oral | 250 mg | $0.104 per tablet | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC), a survey of retail pharmacy invoice prices. Benchmarks shown are the range across package sizes of a representative product for each form and strength — other manufacturers' products may differ.
Ciprofloxacin brand names
Ciprofloxacin is sold under 10 brand names in the FDA directory — Cipro Oral Suspension, Cipro Tablets, Cipro XR Extended-release Tablets, Proquin XR Extended-release Tablets and others. A brand and its generic contain the same active ingredient; the brand name belongs to one company's product.
Who makes Ciprofloxacin: manufacturers and labelers
49 companies list Ciprofloxacin products with the FDA. By number of product records, the largest are PD-Rx Pharmaceuticals, Inc., Bryant Ranch Prepack, NuCare Pharmaceuticals,Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
…and 25 more on the FDA NDC directory.
Ciprofloxacin drug class (RxNorm)
Ciprofloxacin belongs to the Fluoroquinolone Antibacterial class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
Sources for this Ciprofloxacin page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Bayer HealthCare Pharmaceuticals Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →